Logo image of BUJA

BUKIT JALIL GLOBAL ACQUISITI (BUJA) Stock Fundamental Analysis

NASDAQ:BUJA - Nasdaq - KYG1676M1050 - Common Stock - Currency: USD

3.66  -7.03 (-65.76%)

After market: 4.2 +0.54 (+14.75%)

Fundamental Rating

1

Taking everything into account, BUJA scores 1 out of 10 in our fundamental rating. BUJA was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of BUJA have multiple concerns. BUJA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BUJA had positive earnings in the past year.
BUJA had a negative operating cash flow in the past year.
BUJA Yearly Net Income VS EBIT VS OCF VS FCFBUJA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 500K -500K 1M -1M

1.2 Ratios

Industry RankSector Rank
ROA 3.66%
ROE 4%
ROIC N/A
ROA(3y)3.89%
ROA(5y)N/A
ROE(3y)68.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BUJA Yearly ROA, ROE, ROICBUJA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 50 100 150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BUJA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BUJA Yearly Profit, Operating, Gross MarginsBUJA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

BUJA has less shares outstanding than it did 1 year ago.
The debt/assets ratio for BUJA is higher compared to a year ago.
BUJA Yearly Shares OutstandingBUJA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
BUJA Yearly Total Debt VS Total AssetsBUJA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

BUJA has an Altman-Z score of 3.55. This indicates that BUJA is financially healthy and has little risk of bankruptcy at the moment.
BUJA has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 3.55
ROIC/WACCN/A
WACCN/A
BUJA Yearly LT Debt VS Equity VS FCFBUJA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 0.01 indicates that BUJA may have some problems paying its short term obligations.
BUJA has a Quick Ratio of 0.01. This is a bad value and indicates that BUJA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
BUJA Yearly Current Assets VS Current LiabilitesBUJA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M

More info and screens

1

3. Growth

3.1 Past

BUJA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 159.11%, which is quite impressive.
EPS 1Y (TTM)159.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.88, BUJA is valued on the expensive side.
The average S&P500 Price/Earnings ratio is at 26.35. BUJA is around the same levels.
Industry RankSector Rank
PE 22.88
Fwd PE N/A
BUJA Price Earnings VS Forward Price EarningsBUJA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BUJA Per share dataBUJA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BUJA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BUKIT JALIL GLOBAL ACQUISITI

NASDAQ:BUJA (5/8/2025, 8:00:01 PM)

After market: 4.2 +0.54 (+14.75%)

3.66

-7.03 (-65.76%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners58.45%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner Change0%
Market Cap18.08M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.88
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.6
P/tB 0.6
EV/EBITDA N/A
EPS(TTM)0.16
EY4.37%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0
BVpS6.08
TBVpS6.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.66%
ROE 4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.89%
ROA(5y)N/A
ROE(3y)68.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 3.55
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)159.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.32%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-154.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-228.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-228.48%
OCF growth 3YN/A
OCF growth 5YN/A